U.S. Healthcare Services Stock News

Investor Day plan and proposed rebrand put Bladex in focus Banco Latinoamericano de Comercio Exterior S. A (BLX) has moved into the spotlight after its 2026 Investor Day, where management outlined a 2030 plan to build a more transactional regional trade banking platform. The bank also plans to ask shareholders at the April 21, 2026 AGM to approve a name change to Bladex Inc. It will gradually roll out transactional services aimed at growing deposits, payments activity, and fee income. See our...

Cadre Holdings (NYSE:CDRE) has agreed to acquire Alien Gear Holsters through a court supervised bankruptcy auction. The deal remains subject to court and regulatory approvals before closing. Alien Gear Holsters is known for its holster products and direct to consumer sales channels. For investors watching NYSE:CDRE, the move adds a well known holster brand to Cadre Holdings' existing portfolio of safety and protection equipment. Alien Gear Holsters brings an established consumer following...

Stock performance snapshot Arcus Biosciences (RCUS) has drawn investor attention after recent trading left the stock near US$20.28, with returns showing mixed moves over the past week, month and past 3 months. See our latest analysis for Arcus Biosciences. While the recent 1 day share price return of a 4.38% decline and 7 day share price return of a 6.28% decline show pressure at around US$20.28, the 1 year total shareholder return of 148.23% points to strong longer term momentum despite...

Hoyne Bancorp (HYNE) has just posted its FY 2025 figures with third quarter revenue at roughly US$3.5 million and net income at about US$0.1 million, set against trailing 12 month revenue of around US$13.2 million and a loss of roughly US$0.4 million. Over the last few reported periods, the bank has seen revenue move from about US$2.5 million in Q3 2024 to roughly US$3.5 million in Q3 2025, while TTM revenue shifted from around US$10.3 million to about US$13.2 million. This provides a clearer...

Recent share performance and business snapshot Appian (APPN) has drawn investor attention after a period of weaker share performance. The stock has shown negative returns over the past week, month and past 3 months, and a 1 year total return decline of 21%. The company runs The Appian Platform, an automation and low code software offering used across industries such as financial services, government, life sciences and insurance. Its operations are supported by cloud subscriptions, licenses...

If you are wondering whether Rockwell Automation at around US$351.50 is priced for opportunity or already fully valued, the starting point is understanding what the current market price is actually reflecting. The stock has seen mixed recent returns, with a 1% decline over the last 7 days and a 12.6% decline over the last 30 days, while still showing 38.0% over 1 year, 26.1% over 3 years and 45.2% over 5 years. Recent coverage has focused on Rockwell Automation's role in industrial...

In March 2026, KE Holdings Inc. reported weaker fourth-quarter and full-year 2025 earnings, with net income falling year-on-year despite slightly higher annual revenue, while also announcing a reduced final cash dividend of US$0.092 per ordinary share (US$0.276 per ADS) and completing a US$2.55 billion share repurchase program. At the same time, the company’s removal from the FTSE All-World Index for its NYSE listing and inclusion via its Hong Kong listing, combined with negative free cash...

If you are wondering whether Planet Fitness at around US$73.80 is a bargain, a fair deal, or still looks expensive, you are asking the right question before making any move. The stock has seen a 0.7% slip over the last 7 days, a 7.8% decline over the past month, and is down 32.7% year to date and 23.3% over the last year, which can change how the market views its potential and its risks. These price moves sit against a backdrop of ongoing attention on Planet Fitness's position in the fitness...

United Security Bancshares (UBFO) has wrapped up FY 2025 with fourth quarter revenue of US$13.1 million and EPS of US$0.20, alongside trailing 12 month revenue of US$48.3 million and EPS of US$0.71. These figures sit against a five year earnings growth rate of 8.5% per year and a negative one year earnings growth figure. Over recent periods the company has seen revenue move from US$48.6 million and EPS of US$0.86 on a trailing 12 month basis in late 2024 to the latest trailing totals of...

IQVIA Holdings (IQV) has put artificial intelligence at the center of its story by launching IQVIA.ai in collaboration with NVIDIA. The goal is to embed agentic AI directly into life sciences workflows across clinical, commercial and real-world applications. See our latest analysis for IQVIA Holdings. Despite the IQVIA.ai launch and recent broker upgrades, the share price is US$163.85 after a 1 day share price return of a 3.28% decline and a 90 day share price return of a 27.79% decline,...

Wondering if FB Financial at around US$51.21 is a fair deal or starting to look expensive? This breakdown will help you weigh what the current price might be implying. The stock has been mixed lately, with a 0.6% move over the last week, a 12.0% decline over the past month, a 10.5% return over the last year and 73.2% over three years. Recent coverage has focused on FB Financial as part of broader discussions around US regional banks, including how investors are treating banks with...

If you are wondering whether BWX Technologies at around US$202.59 is still offering value after a strong run, you are not alone. The stock has delivered 1.4% over the last 7 days, a 2.7% decline over 30 days, is up 11.4% year to date, and shows a 105.5% return over 1 year, 230.5% over 3 years, and 221.4% over 5 years. This naturally raises questions about what is already priced in. Recent coverage has focused on BWX Technologies as a key player in nuclear and defense-related infrastructure,...

FinVolution Group (NYSE:FINV) has issued 2026 revenue guidance of roughly RMB11.5 billion to RMB12.9 billion, which implies a 5% to 15% year over year decline, and has also completed a US$77.26 million share buyback and announced a new annual dividend. See our latest analysis for FinVolution Group. The share price has recently softened, with a 7 day share price return of 14.96% and a 30 day share price return of 18.96%. The 1 year total shareholder return of 50.59% contrasts with a 3 year...

Modiv Industrial (MDV) just closed out FY 2025 with fourth quarter revenue of US$11.3 million, basic EPS of US$0.01, and funds from operations of US$3.8 million, giving investors a clean snapshot of how cash generation and reported earnings are tracking at the end of the year. Over recent periods, revenue has ranged from US$11.8 million to US$12.0 million a quarter while EPS has swung between a loss of about US$0.31 and a small profit. This puts the latest print into clearer context for...

Dollar Tree (NasdaqGS:DLTR) is expanding its multi price strategy, adding items priced up to $7 across more categories. The company is rolling out clearer signage and assortment changes to address customer concerns about confusing price points. Dollar Tree has completed the sale of Family Dollar and is shifting to a single banner focus. Management plans 400 new store openings and 75 closures in 2026 as part of a broad portfolio review. Dollar Tree, which operates fixed price and multi price...

If you are wondering whether APA still offers value after a strong run in its share price, you are not alone. At a last close of US$44.39, APA has posted returns of 13.5% over 7 days, 59.4% over 30 days, 75.0% year to date, 123.2% over 1 year, 37.9% over 3 years and 171.0% over 5 years. These moves sit against a backdrop of ongoing investor interest in the oil and gas sector, with attention often focused on how companies are positioned for commodity price cycles and capital allocation. For...

Wondering if GE HealthCare Technologies at around US$71.54 is offering value or just noise in a complex market? This article breaks down what the current price might be implying. Over shorter periods the stock has been mixed, with a 1.6% gain over the last 7 days, a 14.9% decline over 30 days, and a 13.6% decline year to date, while the 1 year return stands at a 12.2% decline. These moves have kept investors focused on what might be driving sentiment around GE HealthCare Technologies, from...

AerCap Holdings (NYSE:AER) is back in focus after announcing new lease agreements with Ethiopian Airlines for two Boeing 777-300ERSF freighters, along with a 100 aircraft Airbus A320neo Family order and expanded engine leasing. See our latest analysis for AerCap Holdings. Those new Airbus orders and freighter leases come after a period where the 1 month share price return of 9.64% and 90 day share price return of 7.34% contrast with a strong 1 year total shareholder return of 31.79% and 3...

Paychex (NasdaqGS:PAYX) reported record revenue and operating income, driven by the integration of Paycor and rapid deployment of AI-powered capabilities. The Paycor integration is ahead of schedule, with most targeted cost synergies completed and strong cross selling activity across the combined client base. Management highlighted more than 500 AI powered features now in use, aimed at improving productivity and client experience across Paychex solutions. The board approved a new US$1b stock...

If you are trying to figure out whether Travere Therapeutics at around US$27.92 is attractively priced or not, you will want to see how its current value stacks up against a few different yardsticks. The stock has returned 0.7% over the past week, while the 30 day return is a 9.6% decline and the year to date return is a 29.4% decline. This is set against a 37.1% return over the last year and 26.4% over three years. Those mixed returns have come as investors weigh recent company specific...

Toro (NYSE:TTC) is marking 50 years of partnership with Scholarship America, focused on supporting education for employee families. The milestone highlights a long-running corporate social responsibility program centered on scholarships and educational access. This anniversary underscores Toro's ongoing support for its workforce and surrounding communities beyond its core business. Toro, known for its equipment and solutions for turf, landscaping, and related markets, is spotlighting a side...

Lowe's Companies (NYSE:LOW) has launched a creator driven marketing initiative in partnership with MrBeast. The company is building a Creator Network to work directly with digital creators and reach younger, next generation consumers. The effort focuses on using influencer content to shape purchasing inspiration and home improvement engagement beyond traditional advertising. Lowe's Companies, trading at $236.03, is adding a new layer to its customer outreach by pairing its established home...

Wondering whether BlackLine at around US$37.56 is starting to look appealing on value or still has work to do before it earns a spot on your watchlist. The stock has had a mixed run, with a 15.5% gain over the last 30 days, set against a 30.2% decline year to date and a 25.2% decline over the past year. Recent share price moves sit against a broader backdrop of ongoing attention on software names and how consistently they can convert adoption into durable cash flows. For BlackLine, many...

Earlier this week, Ocugen announced positive 12‑month Phase 2 ArMaDa data for its one‑time gene therapy OCU410 in geographic atrophy secondary to dry age‑related macular degeneration, showing a statistically significant 31% reduction in lesion growth at the optimal dose with a favorable safety profile. The company now plans a Phase 3 registrational trial starting in the third quarter of 2026, positioning OCU410 as a potential alternative to current therapies that require frequent, ongoing...